1. Home
  2. EDSA vs CAPT Comparison

EDSA vs CAPT Comparison

Compare EDSA & CAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • CAPT
  • Stock Information
  • Founded
  • EDSA 2015
  • CAPT 2005
  • Country
  • EDSA Canada
  • CAPT South Korea
  • Employees
  • EDSA N/A
  • CAPT N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • CAPT Blank Checks
  • Sector
  • EDSA Health Care
  • CAPT Finance
  • Exchange
  • EDSA Nasdaq
  • CAPT Nasdaq
  • Market Cap
  • EDSA 13.8M
  • CAPT 16.0M
  • IPO Year
  • EDSA N/A
  • CAPT N/A
  • Fundamental
  • Price
  • EDSA $2.05
  • CAPT $1.11
  • Analyst Decision
  • EDSA Strong Buy
  • CAPT
  • Analyst Count
  • EDSA 2
  • CAPT 0
  • Target Price
  • EDSA $13.00
  • CAPT N/A
  • AVG Volume (30 Days)
  • EDSA 33.4K
  • CAPT 1.3M
  • Earning Date
  • EDSA 08-08-2025
  • CAPT 01-01-0001
  • Dividend Yield
  • EDSA N/A
  • CAPT N/A
  • EPS Growth
  • EDSA N/A
  • CAPT N/A
  • EPS
  • EDSA N/A
  • CAPT N/A
  • Revenue
  • EDSA N/A
  • CAPT $17,389,944.00
  • Revenue This Year
  • EDSA N/A
  • CAPT N/A
  • Revenue Next Year
  • EDSA N/A
  • CAPT N/A
  • P/E Ratio
  • EDSA N/A
  • CAPT N/A
  • Revenue Growth
  • EDSA N/A
  • CAPT 84.70
  • 52 Week Low
  • EDSA $1.55
  • CAPT $0.37
  • 52 Week High
  • EDSA $5.59
  • CAPT $3.11
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 52.89
  • CAPT 56.46
  • Support Level
  • EDSA $1.91
  • CAPT $1.13
  • Resistance Level
  • EDSA $2.14
  • CAPT $1.37
  • Average True Range (ATR)
  • EDSA 0.12
  • CAPT 0.15
  • MACD
  • EDSA 0.02
  • CAPT -0.03
  • Stochastic Oscillator
  • EDSA 64.52
  • CAPT 39.55

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About CAPT Captivision Inc.

Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.

Share on Social Networks: